NeurAxis Statistics
Total Valuation
NeurAxis has a market cap or net worth of $16.38 million. The enterprise value is $13.45 million.
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025, before market open.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeurAxis has 7.22 million shares outstanding. The number of shares has increased by 112.74% in one year.
| Current Share Class | 7.22M |
| Shares Outstanding | 7.22M |
| Shares Change (YoY) | +112.74% |
| Shares Change (QoQ) | +1.41% |
| Owned by Insiders (%) | 25.84% |
| Owned by Institutions (%) | 17.49% |
| Float | 4.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.95 |
| Forward PS | 0.02 |
| PB Ratio | 7.83 |
| P/TBV Ratio | 8.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.75 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.80 |
Financial Efficiency
Return on equity (ROE) is -2,480.49% and return on invested capital (ROIC) is -656.75%.
| Return on Equity (ROE) | -2,480.49% |
| Return on Assets (ROA) | -169.85% |
| Return on Invested Capital (ROIC) | -656.75% |
| Return on Capital Employed (ROCE) | -307.92% |
| Revenue Per Employee | $127,901 |
| Profits Per Employee | -$402,513 |
| Employee Count | 21 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 11.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.21% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 56.54 |
| Average Volume (20 Days) | 36,572 |
Short Selling Information
The latest short interest is 17,292, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 17,292 |
| Short Previous Month | 30,765 |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.39% |
| Short Ratio (days to cover) | 0.55 |
Income Statement
In the last 12 months, NeurAxis had revenue of $2.69 million and -$8.45 million in losses. Loss per share was -$1.22.
| Revenue | 2.69M |
| Gross Profit | 2.32M |
| Operating Income | -7.16M |
| Pretax Income | -15.26M |
| Net Income | -8.45M |
| EBITDA | -7.12M |
| EBIT | -7.16M |
| Loss Per Share | -$1.22 |
Full Income StatementBalance Sheet
The company has $3.70 million in cash and $473,405 in debt, giving a net cash position of $3.22 million or $0.45 per share.
| Cash & Cash Equivalents | 3.70M |
| Total Debt | 473,405 |
| Net Cash | 3.22M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 2.07M |
| Book Value Per Share | 0.30 |
| Working Capital | 1.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.10 million and capital expenditures -$27,776, giving a free cash flow of -$6.13 million.
| Operating Cash Flow | -6.10M |
| Capital Expenditures | -27,776 |
| Free Cash Flow | -6.13M |
| FCF Per Share | -$0.85 |
Full Cash Flow StatementMargins
| Gross Margin | 86.52% |
| Operating Margin | -266.46% |
| Pretax Margin | -306.84% |
| Profit Margin | n/a |
| EBITDA Margin | -265.05% |
| EBIT Margin | -266.46% |
| FCF Margin | n/a |